BDBM349750 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(4,5-dimethyl-4H-1,2,4-triazol-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-20
SMILES: Cc1nnc(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)n1C
InChI Key: InChIKey=RUIZMSHNGSKZPO-UHFFFAOYSA-N
Data: 2 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349750 (2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349750 (2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.50E+4 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair |